Brookstone Capital Management Has $2.38 Million Stake in Danaher Co. (NYSE:DHR)

Brookstone Capital Management trimmed its holdings in Danaher Co. (NYSE:DHR) by 6.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 10,357 shares of the conglomerate’s stock after selling 691 shares during the period. Brookstone Capital Management’s holdings in Danaher were worth $2,377,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Trust Co. of Toledo NA OH lifted its holdings in Danaher by 3.0% during the 4th quarter. Trust Co. of Toledo NA OH now owns 36,121 shares of the conglomerate’s stock worth $8,292,000 after purchasing an additional 1,062 shares during the last quarter. Eastover Investment Advisors LLC lifted its holdings in Danaher by 3.1% during the 4th quarter. Eastover Investment Advisors LLC now owns 6,437 shares of the conglomerate’s stock worth $1,478,000 after purchasing an additional 191 shares during the last quarter. Czech National Bank lifted its holdings in Danaher by 6.4% during the 4th quarter. Czech National Bank now owns 139,378 shares of the conglomerate’s stock worth $31,994,000 after purchasing an additional 8,439 shares during the last quarter. Atlas Brown Inc. lifted its holdings in Danaher by 3.7% during the 4th quarter. Atlas Brown Inc. now owns 3,463 shares of the conglomerate’s stock worth $795,000 after purchasing an additional 123 shares during the last quarter. Finally, ST Germain D J Co. Inc. raised its holdings in Danaher by 13.9% in the 4th quarter. ST Germain D J Co. Inc. now owns 3,558 shares of the conglomerate’s stock valued at $817,000 after acquiring an additional 433 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the subject of several analyst reports. Guggenheim initiated coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective for the company. UBS Group dropped their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a report on Thursday, October 31st. Royal Bank of Canada dropped their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Finally, Stifel Nicolaus lifted their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $286.80.

Danaher Stock Up 0.1 %

Shares of DHR opened at $237.78 on Thursday. The company has a market capitalization of $171.74 billion, a PE ratio of 45.38, a PEG ratio of 4.32 and a beta of 0.83. Danaher Co. has a 12 month low of $222.53 and a 12 month high of $281.70. The stock’s 50-day moving average price is $235.27 and its two-hundred day moving average price is $253.56. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.02 EPS. On average, analysts anticipate that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.45%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s payout ratio is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.